Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777175
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-02-27
Brief Title:
A Retrospective Study Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
Sponsor:
Yongchang Zhang
Organization:
Hunan Province Tumor Hospital
Study Overview
Official Title:
A Retrospective Study Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In advanced non-small cell lung cancer there will be some rare mutations such as ALK KRAS etc The efficacy of these immunotherapies on these different rare mutations has not been reported Therefore we conducted this retrospective clinical study to explore the efficacy of immunotherapy for different rare mutations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None